The Venture Codex Logo

The Venture Codex

Rege Nephro

Med-Pharm Collaboration bldg. Kyoto University, 46-29 Yoshidashimoadachi-cho, Sakyo-ku, Kyoto, 606-8501, Japan

Overview

Biotech company developing renal disease therapeutics and cell therapy.

Total Raised

$174 M

Rounds

3

Links

Verticals

Biotechnology
Manufacturing
Medical
Rental

Investment History

  1. Convertible Note

    Jul 2026

    $11M

    Jafco VenturesTaian Venture CapitalToho HoldingSPARX Asset ManagementMitsubishi UFJ CapitalKyoto University Innovation CapitalJIC Venture Growth InvestmentsDaiwa Corporate Investment

  2. Series B

    Oct 2024

    $151M

    Screen HoldingsToyo SeikanJIC Venture Growth InvestmentsMitsubishi UFJ CapitalNippon Venture CapitalKyoto University Innovation CapitalAsahi KaseiJafco VenturesGlobal BrainITICGolden Asia Fund IIDaiwa Corporate Investment · LeadMitsui Chemicals

  3. Series A

    Jan 2022

    $12M

    Jafco VenturesShimadzu CorporationMitsubishi UFJ CapitalKyoto University Innovation CapitalKyogin Lease & CapitalAsahi KaseiSMBC Venture CapitalDM CapitalM3

Team

Kenji Osafune

Founder & Chief Scientific Advisor

Katsuhisa Yamaguchi

Member of the Board, CFO & General Manager of Finance & Administration Division